Browsing Tag:approved

biogens-alzheimers-drug-approved-by-fda-first-new-therapy-in-nearly-two-decades
The Food and Drug Administration approved Biogen's Alzheimer's drug aducanumab on Monday, making it the first U.S. regulator-approved drug to slow cognitive decline in people with Alzheimer's and the first new drug for the disease in nearly two decades.The FDA's decision was eagerly awaited. The drug, which is marketed under the name Aduhelm, is also expected to generate...
Continue reading
0 Comments
Share